UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 156

Sortiert nach

Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Annals of oncology, 2022-09, Vol.33 (9), p.860-877

2022

Link zum Volltext

Verfügbarkeit prüfen

Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q

Annals of oncology, 2019-11, Vol.30 (11), p.1821-1830

2019

Link zum Volltext

Verfügbarkeit prüfen

Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer

Gynecologic oncology, 2013-07, Vol.130 (1), p.49-53

2013

Link zum Volltext

Verfügbarkeit prüfen

Do stages I–II uterine clear cell carcinoma patients need to be treated as aggressively as patients with serous carcinoma?

Gynecologic oncology, 2015-04, Vol.137, p.35-35

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical behavior of FIGO stage I endometrioid endometrial adenocarcinoma diagnosed as high-grade on preoperative biopsy and low-grade on hysterectomy specimen

Gynecologic oncology, 2017-06, Vol.145, p.102-102

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Early-Stage Uterine Papillary Serous Carcinoma (UPSC) and Carcinosarcoma Treated With Adjuvant Carboplatin/Taxane Chemotherapy and Intravaginal Radiation Therapy (IVRT)

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S497-S497

2014

Link zum Volltext

Verfügbarkeit prüfen

Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer

The New England journal of medicine, 2022-02, Vol.386 (5), p.437-448

2022

Link zum Volltext

Verfügbarkeit prüfen

PD-0332991, a cyclin-dependent kinase 4/6 inhibitor, is an active agent in uterine cancer cells

Gynecologic oncology, 2014-06, Vol.133, p.78-78

2014

Link zum Volltext

Verfügbarkeit prüfen

Survival in patients with uterine carcinosarcoma undergoing sentinel lymph node mapping

Gynecologic oncology, 2015-04, Vol.137, p.199-199

2015

Link zum Volltext

Verfügbarkeit prüfen

335 Lurbinectedin (PM01183) in combination with paclitaxel (P) in patients (pts) with advanced solid tumors

European journal of cancer (1990), 2015-09, Vol.51, p.S66-S66

2015

Link zum Volltext

Verfügbarkeit prüfen

The significance of positive peritoneal cytology in stage III endometrial cancer

Gynecologic oncology, 2013-07, Vol.130 (1), p.e69-e69

2013

Link zum Volltext

Verfügbarkeit prüfen

Nomogram predicting 5-year progression-free survival after secondary surgical cytoreduction for platinum-sensitive recurrent ovarian cancer

Gynecologic oncology, 2014-06, Vol.133, p.100-101

2014

Link zum Volltext

Verfügbarkeit prüfen

Combined modality adjuvant therapy for FIGO stage IIIC endometrial carcinomas

Gynecologic oncology, 2014-06, Vol.133, p.136-136

2014

Link zum Volltext

Verfügbarkeit prüfen

Predicting overall survival after secondary surgical cytoreduction for platinum-sensitive recurrent ovarian cancer: A prognostic nomogram

Gynecologic oncology, 2014-06, Vol.133, p.102-102

2014

Link zum Volltext

Verfügbarkeit prüfen

354 Phase I study of investigational oral mTORC1/2 inhibitor MLN0128: Expansion phase in patients with renal, endometrial, or bladder cancer

European journal of cancer (1990), 2015-09, Vol.51, p.S72-S72

2015

Link zum Volltext

Verfügbarkeit prüfen

Patterns of Relapse in Stage I-II Uterine Papillary Serous Carcinoma Treated With Adjuvant Intravaginal Radiation (IVRT)

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S423-S424

2013

Link zum Volltext

Verfügbarkeit prüfen

Revolving door of obstruction – An analysis of gynecologic oncology readmission

Gynecologic oncology, 2013-07, Vol.130 (1), p.e59-e59

2013

Link zum Volltext

Verfügbarkeit prüfen

Lymph Node Involvement: Indicator or Instigator of Poor Outcome in Stage III Endometrial Cancer?

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S451-S451

2012

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Survival in Ovarian Cancer Brain Metastases

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S481-S482

2011

Link zum Volltext

Verfügbarkeit prüfen

Sentinel lymph node mapping: A valuable tool for assessing nodal metastasis in low grade endometrial cancer with superficial myoinvasion

Gynecologic oncology, 2013-07, Vol.130 (1), p.e10-e11

2013

Link zum Volltext

Verfügbarkeit prüfen

PO-252 ADJUVANT CARBOPLATIN/PACLITAXEL AND INTRAVAGINAL RADIATION FOR STAGE I-II SEROUS ENDOMETRIAL CANCER

Radiotherapy and oncology, 2012-05, Vol.103, p.S101-S102

2012

Link zum Volltext

Verfügbarkeit prüfen

PI3K/AKT pathway alterations in paired primary and recurrent endometrial carcinoma

Gynecologic oncology, 2012-03, Vol.125, p.S6-S7

2012

Link zum Volltext

Verfügbarkeit prüfen

Severe complications and oncologic outcome of stage IB cervical cancer treated with radical surgery and individualized post-operative radiation

Gynecologic oncology, 2012-03, Vol.125, p.S57-S57

2012

Link zum Volltext

Verfügbarkeit prüfen

148P DESTINY-PanTumor02 study of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: Exploratory biomarker analyses of HER2 expression and gene amplification in tissue and plasma

Annals of oncology, 2023-10, Vol.34, p.S239-S240

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 156

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(151)
Mit Volltextzugriff
(141)

Publikationsform

Artikel
(155)
Berichte
(1)

Sprache

Englisch
(156)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(48)
Humans
(38)
Female
(31)
Oncology
(22)
Hematology, Oncology And Palliative Medicine
(21)
Animals
(20)
Biological And Medical Sciences
(16)
Obstetrics And Gynecology
(14)
Gastroenterology And Hepatology
(13)
Endometrial Cancer
(12)
Medical Sciences
(12)
Male
(11)
Mice
(10)
Tumors
(10)
Mice, Nude
(9)
Middle Aged
(9)
Aged
(8)
Rats
(8)
Adult
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q

Corrigendum to ‘Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q': [Annals of Oncology 30 (2019) 1821–1830]

Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer

Do stages I–II uterine clear cell carcinoma patients need to be treated as aggressively as patients with serous carcinoma?

Clinical behavior of FIGO stage I endometrioid endometrial adenocarcinoma diagnosed as high-grade on preoperative biopsy and low-grade on hysterectomy specimen

Comparison of Early-Stage Uterine Papillary Serous Carcinoma (UPSC) and Carcinosarcoma Treated With Adjuvant Carboplatin/Taxane Chemotherapy and Intravaginal Radiation Therapy (IVRT)

Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer

PD-0332991, a cyclin-dependent kinase 4/6 inhibitor, is an active agent in uterine cancer cells

Survival in patients with uterine carcinosarcoma undergoing sentinel lymph node mapping

335 Lurbinectedin (PM01183) in combination with paclitaxel (P) in patients (pts) with advanced solid tumors

The significance of positive peritoneal cytology in stage III endometrial cancer

Nomogram predicting 5-year progression-free survival after secondary surgical cytoreduction for platinum-sensitive recurrent ovarian cancer

Combined modality adjuvant therapy for FIGO stage IIIC endometrial carcinomas

Predicting overall survival after secondary surgical cytoreduction for platinum-sensitive recurrent ovarian cancer: A prognostic nomogram

354 Phase I study of investigational oral mTORC1/2 inhibitor MLN0128: Expansion phase in patients with renal, endometrial, or bladder cancer

Patterns of Relapse in Stage I-II Uterine Papillary Serous Carcinoma Treated With Adjuvant Intravaginal Radiation (IVRT)

Revolving door of obstruction – An analysis of gynecologic oncology readmission

Lymph Node Involvement: Indicator or Instigator of Poor Outcome in Stage III Endometrial Cancer?

Predictors of Survival in Ovarian Cancer Brain Metastases

Sentinel lymph node mapping: A valuable tool for assessing nodal metastasis in low grade endometrial cancer with superficial myoinvasion

PO-252 ADJUVANT CARBOPLATIN/PACLITAXEL AND INTRAVAGINAL RADIATION FOR STAGE I-II SEROUS ENDOMETRIAL CANCER

PI3K/AKT pathway alterations in paired primary and recurrent endometrial carcinoma

Severe complications and oncologic outcome of stage IB cervical cancer treated with radical surgery and individualized post-operative radiation

148P DESTINY-PanTumor02 study of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: Exploratory biomarker analyses of HER2 expression and gene amplification in tissue and plasma

Suchergebnisse filtern